The method of random balance for studying the influence of excipients quantities on technological parameters of tablets based on Origanum vulgare L. dry extract
The aim. The aim of the research was to study the influence of excipients amount on the technological parameters of the compression mixture and tablets based on dry extract of Origanum vulgare L. herb using the method of random balance.
Materials and methods. Objects of the study – Origanum vulgare L. herb dry extract, 8 excipients that have been studied at two quantitative levels. The tablets were prepared by direct compression method. The formulations were designed according to the method of random balance. The technological parameters of the compression mixture and tablets based on Origanum vulgare L. herb dry extract have been studied as a function of quantitative factors: silicon, magnesium carbonate basic, dioxide magnesium aluminometasilicate (Neusilin S1®), isomalt (GalenIQ™720), F-melt® Type C (co-spray dried excipients), sucralose, berry flavor and citric acid.
Results and discussion. The increase in the amount of Neusilin S1®, GalenIQ™720 and F-melt®, and the decrease in the amount of magnesium carbonate basic and silicon dioxide improved the flowability expressed by the Hausner ratio. Results of bulk density and tapped density of the compression mixture depended on the quantities of GalenIQ™720 and F-melt®. All formulations of the prepared tablets had the rapid disintegration and ranging from 6 to 15 minutes. Resistance for crushing and friability tablets’ were improved with a decrease in the amount of silicon dioxide and increase in the amount of Neusilin S1®, F-melt® and sucralose. Higher resistance to moisture of tablets based on Origanum vulgare L. dry extract was obtained by using Neusilin S1®, F-melt® and sucralose on the upper levels.
Conclusions. The tablets based on Origanum vulgare L. herb dry extract were successfully manufactured by direct compression method. The random balance method enabled us to identify the most significant quantitative factors to optimize their composition in the tablets based on the dry extract of Origanum vulgare L. herb.
Influenza (Seasonal) (2018). World health organization. Available at: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
Pelucchi, C., Grigoryan, L., Galeone, C., Esposito, S., Huovinen, P., Little, P., Verheij, T. (2012). Guideline for the management of acute sore throat. Clinical Microbiology and Infection, 18, 1–27. doi: http://doi.org/10.1111/j.1469-0691.2012.03766.x
Oxford, J. S., Leuwer, M. (2011). Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges. International Journal of Clinical Practice, 65 (5), 524–530. doi: http://doi.org/10.1111/j.1742-1241.2011.02644.x
Angotoeva, I. B. (2015). Differentsial'naya diagnostika boley v gorle. Meditsinskiy sovet, 15, 42–46.
Voloshyn, O. I., Harnyk, T. P., Voloshyna, L. O., Vasiuk, V. L. (2013). Liky roslynnoho pokhodzhennia v klinitsi vnutrishnikh khvorob − odyn iz vazhlyvykh shliakhiv vyrishennia problemy komorbidnosti (Ohliad literatury ta vlasni doslidzhennia). Fitoterapiia, 1, 4–9.
Mikheev, A. A. (2017). Prospects of application of vegetable oils as antifungal agents (Literature review). Zaporozhye Medical Journal, 19 (2), 221–226. doi: http://doi.org/10.14739/2310-1210.2017.2.95745
Shayista, Ch., Zahoor, A. K., Phalestine, S. (2013). Medicinal importance of genus Origanum: A review Journal of Pharmacognosy and Phytotherapy, 5 (10), 170–177.
Brdjanin, S., Bogdanovic, N., Kolundzic, M., Milenkovic, M., Golic, N., Kojic, M., Kundakovic, T. (2015). Antimicrobial activity of oregano (Origanum vulgare L.): And basil (Ocimum basilicum L.): Extracts. Advanced Technologies, 4 (2), 5–10. doi: http://doi.org/10.5937/savteh1502005b
Chernetska, S., Bely, N. (2020). Preparation and research of Oregano herb dry extract. Sciences of Europe, 55, 10–12.
Chernetska, S. B., Beley, N. M. (2019). Analysis of the pharmaceutical market of medicines for the treatment of throat diseases. Fitoterapia, 1, 34–37. doi: http://doi.org/10.33617/2522-9680-2019-1-34
Chernetska, S. B., Beley, N. M. (2018). Prospects for a creation of new drugs based on Oregano (Literature review). Fitoterapia, 1, 25–28.
Zivorad, R., Lazic. (2004). Design of experiments in chemical engineering. A practical guide. Weinheim: Wiley-VCH.
Hroshovyi, T. A., Martseniuk, V. P., Kucherenko, L. I., Vronska, L. V., Hureieva, S. M. (2008). Matematychne planuvannia eksperymentu pry provedenni naukovykh doslidzhen v farmatsii. Ternopil: Ukrmedknyha, 377.
State Pharmacopoeia of Ukraine. Vol. 2 (2015). Kharkiv: Derzhavne pidpriemstvo. Ukrayinskiy naukoviy farmakopeyniy tsentr yakosti likarskih zasobiv, 1128.
Barchuk, O. Z., Hroshovyi, T. A., Zaliska, O. M., Shalata, V. Yа., Maksymovych, N. M. (2018). Study of the influence of quantitative factors in creation of tablets of extracts of bilberry leaves, goat’s rue herb and taurine by direct compression method. Pharmaceutical review, 4, 42–48. doi: http://doi.org/10.11603/2312-0967.2018.4.9706
Darzuli, N. P., Hroshovyi, T. A. (2018). Study of quantitative factors on technological properties of compression mixture and tablets of round-leaved wintergreen extract. Pharmaceutical review, 3, 45–51. doi: http://doi.org/10.11603/2312-0967.2018.3.9377
Beley, S. Ya., Hroshovyi, T. A., Beley, N. M. (2018). Substantiation of selection of excipients for obtaining tablets based on Malva Sylvestris L. and Plantago Lanceolata L. dry extracts. Pharmaceutical review, 3, 37–44. doi: http://doi.org/10.11603/2312-0967.2018.3.9358
Denys, A. I., Hroshovyi, T. A. (2012). Doslidzhennia vplyvu kilkisnykh faktoriv na farmako-tekhnolohichni vlastyvosti tabletok ekstraktu lystia topoli kytaiskoi. Pharmaceutical review, 3, 64–66.
Azad, M., Moreno, J., Davé, R. (2018). Stable and Fast-Dissolving Amorphous Drug Composites Preparation via Impregnation of Neusilin® UFL2. Journal of Pharmaceutical Sciences, 107 (1), 170–182. doi: http://doi.org/10.1016/j.xphs.2017.10.007
Juneja, P., Kaur, B., Odeku, O. A., Singh, I. (2014). Development of Corn Starch-Neusilin UFL2 Conjugate as Tablet Superdisintegrant: Formulation and Evaluation of Fast Disintegrating Tablets. Journal of Drug Delivery, 2014, 1–13. doi: http://doi.org/10.1155/2014/827035
Barrios-Vazquez, S. C., Villafuerte-Robles, L. (2013). Functionality of GalenIQ 721 as excipient for direct compression tablets. Journal of Applied Pharmaceutical Science, 3 (4), 8–19.
Chaudhary, S. A., Chaudharya, A. B., Mehta, T. A. (2010). Excipients Updates for Orally Disintegrating Dosage Forms. International Journal of Research in Pharmaceutical Sciences, 1 (20), 103–107.
Copyright (c) 2021 Svitlana Chernetska, Natalia Beley, Mariana Demchuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.